| Literature DB >> 33895795 |
Colleen Malashock1, Andrea Keifer2, Katharine Reisbig1, Craig Reha3, Bryan T Alexander1.
Abstract
In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. © American Society of Health-System Pharmacists 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.Entities:
Keywords: COVID-19 drug treatment; Federally Qualified Health Center partnership; bamlanivimab; monoclonal antibody therapy; pharmacist outreach; pharmacy services
Year: 2021 PMID： 33895795 DOI： 10.1093/ajhp/zxab183
Source DB: PubMed Journal: Am J Health Syst Pharm ISSN： 1079-2082 Impact factor: 2.637